1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014

Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the Lymphoblastic Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lymphoblastic Lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lymphoblastic Lymphoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Lymphoblastic Lymphoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Lymphoblastic Lymphoma to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Lymphoblastic Lymphoma to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Lymphoblastic Lymphoma 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Lymphoblastic Lymphoma Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Lymphoblastic Lymphoma 31
Dec 05, 2010: Pharmacyclics Reports Positive Results From Phase I Study Of PCI-32765 At ASH Annual Meeting 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Sanofi 35
Clinical Trial Overview of Sanofi 35
Jazz Pharmaceuticals plc 36
Clinical Trial Overview of Jazz Pharmaceuticals plc 36
Bristol-Myers Squibb Company 37
Clinical Trial Overview of Bristol-Myers Squibb Company 37
AstraZeneca PLC 38
Clinical Trial Overview of AstraZeneca PLC 38
Eisai Inc. 39
Clinical Trial Overview of Eisai Inc. 39
BioCryst Pharmaceuticals, Inc. 40
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 40
Amgen Inc. 41
Clinical Trial Overview of Amgen Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
National Cancer Institute 42
Clinical Trial Overview of National Cancer Institute 42
Fred Hutchinson Cancer Research Center 46
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 46
The University of Texas M. D. Anderson Cancer Center 48
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 48
Children's Oncology Group 49
Clinical Trial Overview of Children's Oncology Group 49
Memorial Sloan Kettering Cancer Center 50
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 50
Case Comprehensive Cancer Center 51
Clinical Trial Overview of Case Comprehensive Cancer Center 51
St. Jude Children's Research Hospital, Inc. 52
Clinical Trial Overview of St. Jude Children's Research Hospital, Inc. 52
Johann Wolfgang Goethe University Hospitals 53
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 53
Stanford University 54
Clinical Trial Overview of Stanford University 54
University of Washington 55
Clinical Trial Overview of University of Washington 55
Five Key Clinical Profiles 56
Appendix 96
Abbreviations 96
Definitions 96
Research Methodology 97
Secondary Research 97
About GlobalData 98
Contact Us 98
Disclaimer 98
Source 99

List of Tables
Lymphoblastic Lymphoma Therapeutics, Global, Clinical Trials by Region, 2014* 7
Lymphoblastic Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Lymphoblastic Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Lymphoblastic Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Lymphoblastic Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Lymphoblastic Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Lymphoblastic Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Lymphoblastic Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Lymphoblastic Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Lymphoblastic Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Lymphoblastic Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Lymphoblastic Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Lymphoblastic Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Lymphoblastic Lymphoma Therapeutics, Global, Suspended Clinical Trials, 2014* 24
Lymphoblastic Lymphoma Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Lymphoblastic Lymphoma Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Lymphoblastic Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 32
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 33
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 34
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 35
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Jazz Pharmaceuticals plc, 2014* 36
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 37
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 38
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2014* 39
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2014* 40
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 41
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 42
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 46
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 48
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 49
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 50
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014* 51
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children's Research Hospital, Inc., 2014* 52
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2014* 53
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 54
Lymphoblastic Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 55

List of Figures
Lymphoblastic Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Lymphoblastic Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Lymphoblastic Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Lymphoblastic Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Lymphoblastic Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Lymphoblastic Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Lymphoblastic Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Lymphoblastic Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Lymphoblastic Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Lymphoblastic Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Lymphoblastic Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Lymphoblastic Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Lymphoblastic Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Lymphoblastic Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 97

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Hodgkin's Lymphoma Forecast in 17 Major Markets 2016-2026

Epiomic Epidemiology Series: Hodgkin's Lymphoma Forecast in 17 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Hodgkin’s Lymphoma in 17 Major Markets Hodgkin’s Lymphoma (HL) is a cancer (also known as Hodgkin Disease, Hodgkin Lymphoma o ...

Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market  Forecast-2023

Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

Small lymphocytic lymphoma- Market Insights, Epidemiology and Market Forecast-2023

Small lymphocytic lymphoma- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Small lymphocytic lymphoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.